CSIMarket
 


Chromadex Corporation  (CDXC)
Other Ticker:  
 
 

CDXC's Operating Income Growth by Quarter and Year

Chromadex's Operating Income results by quarter and year




CDXC Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -0.17 -1.44 -5.32 -6.08
III Quarter September -1.15 -3.07 -8.84 -4.20
II Quarter June -2.32 -6.39 -5.55 -3.69
I Quarter March -1.97 -7.73 -7.36 -5.89
FY   -5.61 -18.63 -27.07 -19.86



CDXC Operating Income fourth quarter 2023 Y/Y Growth Comment
Chromadex Corporation in the fourth quarter 2023 recorded Operating Loss of $ -0.17 millions.

According to the results reported in the fourth quarter 2023, Chromadex Corporation achieved the best Operating Income growth in Legal Cannabis industry. While Chromadex Corporation' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


CDXC Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Chromadex's fourth quarter 2023 Operating Income $ -0.17 millions CDXC's Income Statement
Chromadex's fourth quarter 2022 Operating Income $ -1.44 millions Quarterly CDXC's Income Statement
New: More CDXC's historic Operating Income Growth >>


CDXC Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Chromadex's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDXC's IV. Quarter Q/Q Operating Income Comment
Even if Chromadex Corporation in the IV. Quarter 2023 revealed Operating Loss of $ -0.17 millions, some analyst said, that those numbers point to recovery compare to the -1.15 millions in the third quarter.

Within Legal Cannabis industry Chromadex Corporation achieved highest sequential Operating Income growth. While Chromadex's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDXC's IV. Quarter Q/Q Operating Income Comment
Despite the fact, that Chromadex Corporation in the IV. Quarter 2023 revealed Operating Loss of $ -0.17 millions, management mentioned, that those numbers point to recovery in contrast to the -1.15 millions in the third quarter.

Within Legal Cannabis industry Chromadex Corporation achieved highest sequential Operating Income growth. While Chromadex's Operating Income growth quarter on quarter, overall rank is .


Chromadex's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ -5.60 $ -6.88 $ -8.79 $ -12.86 $ -18.63
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Chromadex Corporation achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Chromadex Corporation achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Legal Cannabis Industry Operating Income Growth Trends and Statistics
Consumer Non Cyclical Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CDXC's Operating Income Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CDXC's Competitors
Operating Income Growth for Chromadex's Suppliers
Operating Income Growth for CDXC's Customers

You may also want to know
CDXC's Annual Growth Rates CDXC's Profitability Ratios CDXC's Asset Turnover Ratio CDXC's Dividend Growth
CDXC's Roe CDXC's Valuation Ratios CDXC's Financial Strength Ratios CDXC's Dividend Payout Ratio
CDXC's Roa CDXC's Inventory Turnover Ratio CDXC's Growth Rates CDXC's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2023 within Consumer Non Cyclical SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Altria Group Inc -0.78%$ -0.781 millions
Andina Bottling Co Inc-1.14%$ -1.142 millions
Philip Morris International Inc -1.20%$ -1.197 millions
Bellring Brands Inc -2.93%$ -2.926 millions
Anheuser busch Inbev Sa-3.80%$ -3.796 millions
Treehouse Foods Inc -11.71%$ -11.706 millions
Hershey Co-11.83%$ -11.833 millions
Golden Growers Cooperative-12.67%$ -12.668 millions
Edgewell Personal Care Company-16.61%$ -16.613 millions
Inter Parfums Inc -18.67%$ -18.666 millions
Archer daniels midland Co-24.61%$ -24.608 millions
Darling Ingredients Inc -36.27%$ -36.271 millions
B and g Foods inc -37.21%$ -37.210 millions
The Davey Tree Expert Company-49.93%$ -49.928 millions
Tyson Foods Inc -50.54%$ -50.535 millions
Brasilagro Brazilian Agricultural Real Estate Comp-60.04%$ -60.036 millions
Mosaic Co-60.25%$ -60.248 millions
Primo Water Corp-64.10%$ -64.098 millions
Cf Industries Holdings inc -64.82%$ -64.822 millions
Icl Group Ltd -67.55%$ -67.548 millions
Chase General Corp-70.71%$ -70.705 millions
Medifast Inc -73.39%$ -73.386 millions
Kellanova-77.91%$ -77.910 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com